Levels of Diagnostic and Therapeutic Intervention in Hospitalized Patients

ConditionAcute Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorConsorci Sanitari de l'Alt Penedès i Garraf

About this trial

The objective of this clinical trial is to investigate the impact of implementing a tool for adjusting the level of diagnostic and therapeutic intensity in the clinical practice of physicians attending hospitalized patients.

The goal of this clinical trial is to investigate the impact of a tool for adjusting diagnostic and therapeutic intensity in hospitalized patients. The main question it aims to answer is: Is there a difference in patient mortality when using the aforementioned tool? The participating physicians will be grouped into 4 groups (5 physicians each). Each group will progressively (every 3 months) incorporate the use of the aforementioned tool into their usual clinical practice.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Physician belonging to the non-surgical medical area.

Routine clinical activity on a hospital ward caring for hospitalized patients.

Disqualifiers

Physician belonging to the Oncology-Hematology/Palliative Care Hospitalization Unit.

Refusal to participate in the study.

Trial design

Design model

Sequential

Treatments tested in this trial

  • Levels of Diagnostic and Therapeutic Intervention tool by Fontecha and col.

    Other intervention

    During the intervention periods, participating physicians will integrate into their usual clinical practice a tool for adjusting diagnostic and therapeutic intensity designed by Fontecha-Gómez and colleagues. The tool for adjusting the level of diagnostic and therapeutic intensity classifies patients' profiles into 5 groups based on the recommended level of adjustment.

  • Usual clinical practice

    Other intervention

    The participating physicians will carry out the standard clinical practice currently performed in the study centers. This means that during this period, the diagnostic and therapeutic adjustment tool or any similar tool will not be introduced into routine clinical practice.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Levels of Diagnostic and Therapeutic Intervention toolExperimental treatment 1 intervention
Group B: Usual clinical practiceActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

In-hospital Patient Mortality at 90 days from hospital discharge

Percentage of patients who die during hospitalization until 90 days from hospital discharge.

Time frame
90 days from hospital discharge

Secondary outcomes

1

In-hospital Patient Mortality at 6 months from hospital discharge

Percentage of patients who die during hospitalization until 6 months from hospital discharge.

Time frame
6 months from hospital discharge
2

In-hospital Patient Mortality at 1 year from hospital discharge

Percentage of patients who die during hospitalization until 1 year from hospital discharge.

Time frame
1 year from hospital discharge
3

Delirium Incidence

Percentage of patients with delirium occurrence during hospital admission (delirium already present at the time of admission will not be considered). Delirium will be evaluated through Confusion Assessment Method (CAM)

Time frame
hospital discharge, assessed up to day 90
4

Pressure Ulcer Incidence

Percentage of patients with pressure ulcer occurrence during hospital admission (pressure ulcers already present at the time of admission will not be considered).

Time frame
hospital discharge, assessed up to day 90

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: